Abstract:Circulation Research, Ahead of Print. Background:FLNC (filamin C), a member of the FLN family predominantly expressed in striated muscles, plays a crucial role in bridging the cytoskeleton and ECM (extracellular matrix) in cardiomyocytes, thereby maintaining heart integrity and function. Although genetic variants within the N-terminal ABD (actin-binding domain) of FLNC have been identified in patients with cardiomyopathy, the precise contribution of the actin-binding capability to FLNC's function in mammalian hearts remains poorly understood.Methods:We conducted in silico analysis of the 3-dimensional structure of mouse FLNC to identify key amino acid residues within the ABD that are essential for FLNC's actin-binding capacity. Subsequently, we performed coimmunoprecipitation and immunofluorescent assays to validate the in silico findings and assess the impact of these mutations on the interactions with other binding partners and the subcellular localization of FLNC. Additionally, we generated and analyzed knock-in mouse models in which the FLNC-actin interaction was completely disrupted by these mutations.Results:Our findings revealed that F93A/L98E mutations completely disrupted FLNC-actin interaction while preserving FLNC's ability to interact with other binding partners ITGB1 (β1 integrin) and γ-SAG (γ-sarcoglycan), as well as maintaining FLNC subcellular localization. Loss of FLNC-actin interaction in embryonic cardiomyocytes resulted in embryonic lethality and cardiac developmental defects, including ventricular wall malformation and reduced cardiomyocyte proliferation. Moreover, disruption of FLNC-actin interaction in adult cardiomyocytes led to severe dilated cardiomyopathy, enhanced lethality and dysregulation of key cytoskeleton components.Conclusions:Our data strongly support the crucial role of FLNC as a bridge between actin filaments and ECM through its interactions with actin, ITGB1, γ-SAG, and other associated proteins in cardiomyocytes. Disruption of FLN-actin interaction may result in detachment of actin filaments from the extracellular matrix, ultimately impairing normal cardiac development and function. These findings also provide insights into mechanisms underlying cardiomyopathy associated with genetic variants in FLNC ABD and other regions.

Molecular Basis of Filamin A-FilGAP Interaction and Its Impairment in Congenital Disorders Associated with Filamin A Mutations.

Structural basis of filamin A functions.

Mechanism of Filamin A (flna) Actin Filament (f‐actin) Crosslinking

The Filamins

Cystic Fibrosis Transmembrane Conductance Regulator Interacts with Multiple Immunoglobulin Domains of Filamin A

Differential Mechanical Stability of Filamin a Rod Segments and Domain Pair Interaction

Abstract 17551: Mapping the Interactome of FLNC in Restrictive Cardiomyopathy

Abstract P2020: Binding of Filamin C with Actin is Essential for Cardiac Development and Function

The filamins Organizers of cell structure and function

Role of Filamin C in Muscle Cells

The function and pathogenic mechanism of filamin A

Identification of Filamin A Mechanobinding Partner I: Smoothelin Specifically Interacts with the Filamin A Mechanosensitive Domain 21

Filamin A (flna) is Required for Cell-Cell Contact in Vascular Development and Cardiac Morphogenesis

Interaction of Filamin C With Actin Is Essential for Cardiac Development and Function

Pathogenic FLNA variants affecting the hinge region of filamin A are associated with male survival

Filamin A mutation is one cause of FG syndrome

Electron Microscopy And 3d Reconstruction Reveals Filamin Ig-Domain Binding To F-Actin.

Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias

Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact

Distinct molecular features of FLNC mutations, associated with different clinical phenotypes

The filamin-B–refilin axis – spatiotemporal regulators of the actin-cytoskeleton in development and disease